HIV, co-morbidity and ageing

HIV, co-morbidity and ageing

As treatment for HIV infection needs to be used continuously and lifelong, issues concerning long-term outcomes, including those involving tolerability and safety of treatment, are gaining increasing importance. Although current combination antiretroviral therapy (cART) regimens are generally better tolerated than those in the early days of cART, treatment toxicity remains an important cause fo...

HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.

More than 25 antiretroviral drugs from six therapeutic classes are now available for the management of HIV infection (box 1). Most patients who take medication achieve durable and perhaps lifelong viral suppression, so the classic AIDS related conditions are becoming less common. However, treated patients do not have completely restored health. Compared with people without HIV infection, patien...

Co-Morbidity of HIV and Malaria in Sub-Saharan Africa

HIV and Malaria remain two of the greatest risks of global health, accounting for massive morbidity and mortality rates. These diseases are of greatest prevalence in low-income and tropical areas, and overlap most significantly in Sub-Saharan Africa. This is a review of the interactions between these infections, and their treatments.

DOCTORAL DISSERTATION Aging and co-morbidity among HIV-infected individuals

Co-Morbidity of Obsessive Compulsive Disorder and Tourette Syndrome

Objectives: Tourette syndrome is a disease with vocal and motor tics. This disorder is co-morbid with many psychiatric disorders, among which obsessive-compulsive disorder is the most common. Methods: During a one-year period, 30 patients with Tourette disorder were studied at an adolescent psychiatry referral clinic. It was an analytical-descriptive study. Subjects were selected by convenie...